Volume 9, Issue 4 pp. 536-544

Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria

Dao-Fu Dai

Dao-Fu Dai

Department of Pathology, University of Washington, Seattle, WA 98195, USA

Search for more papers by this author
Tony Chen

Tony Chen

Department of Pathology, University of Washington, Seattle, WA 98195, USA

Search for more papers by this author
Jonathan Wanagat

Jonathan Wanagat

Department of Medicine, Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Search for more papers by this author
Michael Laflamme

Michael Laflamme

Department of Pathology, University of Washington, Seattle, WA 98195, USA

Search for more papers by this author
David J. Marcinek

David J. Marcinek

Departments of Radiology

Bioengineering

Search for more papers by this author
Mary J Emond

Mary J Emond

Biostatistics, University of Washington, Seattle, WA 98195, USA

Search for more papers by this author
Calvin P. Ngo

Calvin P. Ngo

Department of Pathology, University of Washington, Seattle, WA 98195, USA

Search for more papers by this author
Tomas A. Prolla

Tomas A. Prolla

Departments of Genetics & Medical Genetics, University of Wisconsin-Madison, WI 53706, USA

Search for more papers by this author
Peter S. Rabinovitch

Peter S. Rabinovitch

Department of Pathology, University of Washington, Seattle, WA 98195, USA

Search for more papers by this author
First published: 21 July 2010
Citations: 229
Peter S. Rabinovitch, Department of Pathology, University of Washington, 1959 Pacific Ave NE, HSB-K081, Seattle, WA 98195, USA. Tel.: 206 685 3761; fax: 206 616 8271; e-mail: [email protected]

Summary

Mitochondrial defects have been found in aging and several age-related diseases. Mice with a homozygous mutation in the exonuclease encoding domain of mitochondrial DNA polymerase gamma (Polgm/m) are prone to age-dependent accumulation of mitochondrial DNA mutations and have shown a broad spectrum of aging-like phenotypes. However, the mechanism of cardiac phenotypes in relation to the role of mitochondrial DNA mutations and oxidative stress in this mouse model has not been fully addressed. We demonstrate age-dependent cardiomyopathy in Polgm/m mice, which by 13–14 months of age displays marked cardiac hypertrophy and dilatation, impairment of systolic and diastolic function, and increased cardiac fibrosis. This age-dependent cardiomyopathy is associated with increases in mitochondrial DNA (mtDNA) deletions and protein oxidative damage, increased expression of apoptotic and senescence markers, as well as a decline in signaling for mitochondrial biogenesis. The relationship of these changes to mitochondrial reactive oxygen species (ROS) was tested by crossing Polgm/m mice with mice that overexpress mitochondrial targeted catalase (mCAT). All of the above phenotypes were partially rescued in Polgm/m/mCAT mice. These data indicate that accumulation of mitochondrial DNA damage with age can lead to cardiomyopathy and that this phenotype is partly mediated by mitochondrial oxidative stress.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.